●
Analytical verification
Each antibody is tested on relevant cell-line and cytology backgrounds — staining intensity, specificity, background, and lot-to-lot consistency.
Public X-ZELL resources position the platform around direct-to-slide preparation, multiplex staining and digital review. We present evidence carefully and distinguish analytical, workflow and clinical context.
Regulatory note: Product availability, regulatory status, and intended use may vary by market. Please contact X-ZELL for current documentation.
We separate analytical performance, multiplex compatibility, and clinical performance — and document each independently.
Each antibody is tested on relevant cell-line and cytology backgrounds — staining intensity, specificity, background, and lot-to-lot consistency.
Panels are scored for spectral compatibility, cross-reactivity, and antigen-retrieval interactions before release.
Clinical performance is established with partners in the intended patient-specimen context. We do not extrapolate from analytical data.
Documentation scaled to the partnership type — from research collaborations to OEM/IVD development.
A concise evidence layer for cytology laboratories evaluating multiplex cryoimmunostaining. Details should be interpreted in the intended specimen and regulatory context.
Peer-reviewed preliminary evaluation of multiplex cryoimmunostaining on routinely prepared cytospin samples from fine-needle aspiration biopsies and effusions.
Read article →Conference abstract listed in X-ZELL resources, relevant to effusion cytology workflows and routine-laboratory evaluation.
View resources →Public X-ZELL news describes interim German study data comparing NGC with conventional cell-blocking and IHC approaches for minimally invasive samples.
Read summary →Foundational publication referenced by X-ZELL for multi-channel fluorescence detection, relevant to the technical rationale for multiplex review.
See literature list →Shortcuts for teams evaluating workflow fit, panel availability or technical documentation.
A concise visual overview of the platform, intended as a first-pass resource for internal evaluation.
Open brochure →Definitions for Cryoimmunostaining™, Cryophore™, Hybrid Microscope and Next-Generation Cytology.
View glossary →Product availability, intended use and regulatory status vary by market. Request current documentation before procurement.
Request dossier →Our scientific liaison team can provide the analytical and quality documentation under NDA for qualified institutions.